Suggested algorithm for bone marrow biopsy and skeletal imaging in patients with monoclonal gammopathy of undetermined significance. #Mayo Clinic Risk.

Slides:



Advertisements
Similar presentations
MGUS (interpreting the test you didnt order) Family Medicine Review Course 2011 Christian Cable, MD, FACP.
Advertisements

PLASMA CELL DYSCRASIAS Monoclonal gammopathy of uncertain significance (MGUS)  Idiopathic  Associated with other diseases (autoimmune, infectious, non-heme.
Staff Oncologist, Mayo Clinic Arizona
Long-Term Biological Variation of Serum Protein Electrophoresis M-Spike, Urine M-Spike, and Monoclonal Serum Free Light Chain Quantification: Implications.
Waldenström’s Macroglobulinemia And the Hyperviscosity Syndromes.
Plasma cell neoplasm Plasma cell Ig M component, para protein Monoclonal gammopathy.
Educational Presentation. Program Overview Provide information on The Leukemia & Lymphoma Society Describe blood cancers Explain Pennies for Patients.
Cancer Among Native Americans in Arizona and New Mexico Data Provided by Arizona Cancer Registry at the Arizona Department of Health Services and the New.
Plasma cell disorders Dr. hassanali vahedian ardakani Medical oncologist hematologist 2013.
Multiple Myeloma Definition: B-cell malignancy characterised by abnormal proliferation of plasma cells able to produce a monoclonal immunoglobulin (M protein)
Plasma cell Disorders S. Sami Kartı, MD, Prof.. Plasma cells  Terminally differentiated cells of B- lymphocyte lineage  Produce antibodies  Normal.
Multiple Myeloma Definition:
Laboratory Management. ITP is suspected in patients with isolated thrombocytopenia Because manifestations of ITP are nonspecific, other causes of isolated.
1.Defining Plasma cell disorders/Multiple Myeloma 2.Identification of different plasma cell disorders. 3.Diagnosis and workup for plasma cell disorders/Multiple.
Stem cell concepts renew cancer research by John E. Dick Blood Volume 112(13): December 15, 2008 ©2008 by American Society of Hematology.
Plasma cell dyscrasias. Multiple Myeloma By Dr. Muna A. Kashmool.
How do organs work together? Organs work together in organ systems to carry out major life functions.
Multiple Myeloma March 13, 2012 Suzanne R. Fanning, DO Greenville Health System.
Case Study Multiple Myeloma.
Multiple Myeloma in Session 2015: An Online Journal Club for Hematology/Oncology Fellows This program is supported by educational grants from Celgene Corporation.
Controversies in multiple myeloma: Evidence-based update
MLAB Hematology Keri Brophy-Martinez
Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression  Weixin Wang, Meghan Corrigan-Cummins,
Leukemia Skeletal system
MLAB Hematology Fall 2007 Keri Brophy-Martinez
UR Medicine at Ridgeland Road Clinical Trials Central Laboratory
by Robert A. Kyle, Morie A. Gertz, Philip R. Greipp, Thomas E
How I treat LGL leukemia
A Prospective Randomized Trial of Buffy Coat Versus CD34-Selected Autologous Bone Marrow Support in High-Risk Breast Cancer Patients Receiving High-Dose.
by Christopher Dittus, and Dana Semmel
Hafsa M. Chaudhry, BA, Michelle L. Mauermann, MD, S
Clues to a Diagnosis: A Focus on Light-Chain Amyloidosis
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
Monoclonal Gammopathy of Undetermined Significance
How I treat hairy cell leukemia
by Rafael Fonseca, Richard J. Bailey, Gregory J. Ahmann, S
P16 INK4a andp15 INK4b gene methylations in plasma cells from monoclonal gammopathy of undetermined significance by Gaëlle Guillerm, Emmanuel Gyan, Darius.
How to Treat MDS without Stem Cell Transplantation
A young patient with multiple myeloma
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification system by.
Monoclonal Gammopathy–Associated Proliferative Glomerulonephritis
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia by Anna Rogers, Youngson.
Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma by Rishi K.
Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma by Mohammed A. Aljama, M. Hasib Sidiqi, Arjun.
ROCK and Rho(ll) in bone marrow
Hyperviscosity syndrome
Anemia Rachel McNair.
Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression  Weixin Wang, Meghan Corrigan-Cummins,
Renal Manifestations of Plasma Cell Disorders
Christophe Sirac, Frank Bridoux  Kidney International 
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma by Angela Dispenzieri,
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
Myeloma: Symptoms to diagnosis Can we do better?
New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation  Anita D'Souza,
Treatment-based approach to HESs
Prepared by staff in Prevention and Cancer Control.
Incidence of Monoclonal Gammopathy of Undetermined Significance and Estimation of Duration Before First Clinical Recognition  Terry M. Therneau, PhD,
John E. Levine, Sophie Paczesny, Stefanie Sarantopoulos 
Mammen Chandy  Biology of Blood and Marrow Transplantation 
Treatment versus Transplant for Challenging Hematologic Disorders
Pain. Pain. (A) Skeletal pain experienced by bone marrow (BM) and peripheral blood stem cell (PBSC) donors at baseline, during the pericollection period,

Resistance mechanism for ibrutinib in marginal zone lymphoma
by Robert A. Kyle, and S. Vincent Rajkumar
Mary Eapen  Biology of Blood and Marrow Transplantation 
Pure red cell aplasia by Robert T. Means Blood
by Lapo Alinari, and Kristie A. Blum
How to establish the diagnosis of LGL leukemia.
Stem cell transplant in MF: it’s time to personalize
Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis by.
Presentation transcript:

Suggested algorithm for bone marrow biopsy and skeletal imaging in patients with monoclonal gammopathy of undetermined significance. #Mayo Clinic Risk Stratification Model. *No unexplained symptoms or laboratory features concerning for serious plasma cell d... Suggested algorithm for bone marrow biopsy and skeletal imaging in patients with monoclonal gammopathy of undetermined significance. #Mayo Clinic Risk Stratification Model. *No unexplained symptoms or laboratory features concerning for serious plasma cell disorder. Ronald S. Go, and S. Vincent Rajkumar Blood 2018;131:163-173 ©2018 by American Society of Hematology

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.